|
1) |
Nag S, Beyer D, Friedland J, et al. American Brachytherapy Society(ABS)recommendations for transperineal permanent bracytherapy of the prostate cancer. Int J Radiat Oncol Biol Phys. 1999;44(4):789-99. |
2) |
Blasko J, Ragde H, Cavanagh W, et al. Long-term outcomes of external beam irradiation and I-125/Pd-103 brachytherapy boost for prostate cancer. Int J Radiat Oncol Biol Phys. 1996;36(Suppl 1):198. |
3) |
Critz FA, Tarlton RS, Holladay DA. Prostate-specific antigen monitored combination radiotherapy for patients with prostate cancer. Cancer. 1995;75:2383-91. |
4) |
Radge H, Elgamal AA, Snow PB, et al. Ten year disease-free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-Gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma. Cancer. 1998;83:989-1001. |
5) |
RTOG homepage http://www.rtog.org |